First human test for new heart failure drug begins
Knowledge-focused
Recruiting now
This is an early-stage study to check the safety and tolerability of a new drug called VS-041 in people with a specific type of heart failure (HFpEF). It will involve 42 participants and will closely monitor for any side effects. The study will also measure changes in certain blo…
Phase: PHASE1 • Sponsor: Vasa Therapeutics • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC